Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27913/fullpdf
Reference63 articles.
1. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med.,2010
2. US Food and Drug Administration (FDA) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm269856.htm
3. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy;Webb;Expert Rev Anticancer Ther.,2009
4. Treating ALK-positive lung cancer-early successes and future challenges;Camidge;Nat Rev Clin Oncol.,2012
5. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer;Mano;Cancer Sci.,2008
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted therapeutic options in early and metastatic NSCLC-overview;Pathology and Oncology Research;2024-03-28
2. Therapeutic options for lung cancer with ALK or ROS1 (+) rearrangement. First line and progression management;Revisiones en Cáncer;2023
3. Treatment of Stage IV Non-small Cell Lung Cancer;Respiratory Medicine;2023
4. Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies;JCO Precision Oncology;2022-07
5. Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System;Targeted Oncology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3